Company: STAA
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284603
Chunk: 10

Company: STAAR SURGICAL CO
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 10
---
2025, Broadwood and other members of the Broadwood Group filed a definitive proxy statement with the SEC to solicit votes of STAAR stockholders in opposition to the Board’s recommendations on the Merger Proposal and Compensation Proposal presented in this proxy statement. In addition, Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”) has reported beneficial ownership as of October 31, 2025 of 5.1% of STAAR’s outstanding shares of common stock, and has indicated that it intends to vote against the Merger Proposal.If STAAR’s largest stockholders do not vote their shares in support of the adoption of the Merger Agreement, STAAR’s ability to satisfy this closing condition would be materially adversely affected. Further, there can be no guarantee that any alternative proposals will be received during the go-shop period, that any such alternative proposals would be superior to the Alcon merger, or that such competitive process will result in an increase to the merger consideration payable by Alcon, andSTAAR may be unable to obtain the votes required to approve the se proposals Merger Proposal and the Compensation Proposalin the absence of any change to the terms of the Merger Agreement. The proxy contest resulting from the Broadwood Group filing will cause STAAR stockholders to incur additional solicitation and other costs, and may impair STAAR’s ability to obtain the votes required to approve the Merger Proposal and Compensation Proposal. . . . The Merger Agreement also includes termination provisions for both STAAR and Alcon. If the Merger Agreement is terminated under specified circumstances, STAAR may be required to pay Alcon a termination fee of up to $43,425,000, and if the Merger Agreement is terminated under certain circumstances, including a failure to timely receive required regulatory approvals, Alcon may be required to pay STAAR a termination fee of $72,375,000. Pursuant to the Amendment, the termination fee payable by STAAR to Alcon has been reduced to $0 in certain circumstances, including if STAAR terminates the Merger Agreement to accept a Superior Offer from a Qualified Bidder. 9

The first paragraph of the risk factor titled “The Merger Agreement contains provisions that could discourage a potential competing acquiror of STAAR” on page 25 of the proxy statement is hereby amended and supplemented as follows:

The Merger Agreement contains non-solicitation provisions that, subject to certain
exceptions, restrict STAAR’s ability to solicit, initiate, knowingly encourage or facilitate